LOVFF

Healthcare Drug Manufacturers - Specialty & Generic

Cannara Biotech Inc.

$1.53
+0.05 +3.38% today

Price History

Not enough data

Key Stats

Market Cap
151.14M
Avg Volume
9,478
P/E (TTM)
18.50
EPS
$0.08
52W High
$1.66
52W Low
$1.11
Div. Yield
0.0%

Valuation

P/B Ratio
1.65
P/S Ratio
1.25
EV/EBITDA
6.53
EV/Revenue
1.38

Margins

Gross Margin 42.6%
Operating Margin 23.1%
Net Margin 9.3%
EBITDA Margin 21.1%

Growth & Returns

Revenue Growth (YoY)
16.4%
Earnings Growth (YoY)
22.6%
Earnings Growth (QoQ)
16.9%
Return on Equity
9.7%
Return on Assets
6.3%

Liquidity & Leverage

Current Ratio
3.00
Quick Ratio
1.24
Debt / Equity
0.29
Total Cash
21.81M
Total Debt
37.00M

About

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

cannara.ca